Agents and Actions

, Volume 7, Issue 3, pp 313–315 | Cite as

Prejudices in pharmacology and pharmacotherapy. The so-called anticholinergic effect of antidepressants

  • Hugo-J. Bein
Article

Abstract

Imipramine and similarly acting compounds provoke a number of undesired reactions usually classified as so-called anticholinergic effects. Instances of dry mouth, disturbance of micturition and tachyeardia are regularly quoted in the literature. It is contended that these effects are not necessarily due to inhibition of the vagal system, but preferentially attributable to increased activity of the sympathetic system, predominantly mediated by the β-or the α-adrenergic receptors, depending on the organ affected. This hypothesis is not only theoretically interesting, but also of practical clinical significance with regard to possible remedies.

Keywords

Clinical Significance Imipramine Anticholinergic Effect Sympathetic System Undesired Reaction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    R. Kuhn,Ueber die Behandlung depressiver Zustäne mit einem Iminodibenzylderivat (G 22355), Schweiz. med. Wschr.87, 1135–1140 (1957).PubMedGoogle Scholar
  2. [2]
    M.H. Lader,The Clinical pharmacology of Anti-Depressives, J. Int. Med. Res.3, Supplement (3), 31–40 (1975).Google Scholar
  3. [3]
    H. Brunner, P.R. Hedwall, M. Meier andH.J. Bein,Cardiovascular Effects of Preparation CIBA 34, 276-Ba and Imipramine, Agents and Actions,2, 69–82 (1971).PubMedGoogle Scholar
  4. [4]
    G. Ritter andF. Grabner Psychopharmaka und Miktionsstörungen, Der Nervenarzt41, 232–233 (1970).PubMedGoogle Scholar
  5. [5]
    S.A. Awad, A.W. Bruce, G. Carro-Ciampi, J.W. Downie, M. Lin andG.S. Marks,Distribution of alpha- and beta-Adrenoceptors in Human Urinary Bladder, Br. J. Pharmac.50, 525–529 (1974).Google Scholar
  6. [6]
    G. Harrer,Ueber Affekt-und Blaseninkonitenz. Ein Beitrag zum affektiv-vegetativen Reiz-und Erschöpfungssyndrom Birkmayers, Wien. med. Wschr.125, 21, 341–344 (1975).PubMedGoogle Scholar
  7. [7]
    H. Hilgers andR. Kuhn, personal communication (1974).Google Scholar
  8. [8]
    G. Daudet,Traitement et prévention des Troubles neuro-végétatifs et circulatoires induits par les Psychotropes, au moyen de la D.H.E. 45, Annales de Neuro-Psychiatrie de Clermont-Ferrand, 113–120 (1972).Google Scholar
  9. [9]
    J. P. Lumineau, M.J. Garraud andA. Gaillard,Action de la Dihydroergotamine sur les Complications salivaires des Traitements psychotropes, L'Ouest Médical25, 85–89 (1972).Google Scholar
  10. [10]
    J. Danjard,La Dihydroergotamine, adjuvant indispensable de l'arsenal thérapeutique psychiatrique. Psychologie Médicale5, 181–182 (1973).Google Scholar
  11. [11]
    M.O. Jaskari, U.G. Ahlfors, L. Ginman, K. Lydekcne andP. Tienari,Three Double-Blind Comparative Trials of Mianserine (ORG GB 94) and Amitriptyline in the Treatment of Depressive Illness. Pharmacopsych.10, 101–103 (1977).Google Scholar

Copyright information

© Birkhäuser Verlag 1977

Authors and Affiliations

  • Hugo-J. Bein
    • 1
  1. 1.Oberwill

Personalised recommendations